For: | State M, Negreanu L, Voiosu T, Voiosu A, Balanescu P, Mateescu RB. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World J Gastroenterol 2021; 27(16): 1828-1840 [PMID: 33967560 DOI: 10.3748/wjg.v27.i16.1828] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i16/1828.htm |
Number | Citing Articles |
1 |
Seung Bum Lee, Hyun-Ki Kim, Sang Hyuk Park, Ji-Hun Lim, Sang Hyoung Park. Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease. Intestinal Research 2024; 22(1): 75 doi: 10.5217/ir.2023.00065
|
2 |
Monica State, Paul Balanescu, Theodor Voiosu, Andreea Bengus, Andrei Voiosu, Andrei Coman, Petronel Mustatea, Lucian Negreanu, Radu Bogdan Mateescu, Cristiana Popp. Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study. Biomedicines 2023; 11(7): 1860 doi: 10.3390/biomedicines11071860
|
3 |
Min Wang, Jingyan Shi, Chao Yu, Xinyi Zhang, Gaoxin Xu, Ziyan Xu, Yong Ma. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298186
|
4 |
Toshiyuki Sakurai, Masayuki Saruta. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease. Digestion 2023; 104(1): 30 doi: 10.1159/000527846
|
5 |
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M. Toivola. Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26603-2
|
6 |
Markus F Neurath, Michael Vieth. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut 2023; 72(11): 2164 doi: 10.1136/gutjnl-2023-329964
|
7 |
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
|
8 |
Hisashi Hirayama, Yasuhiro Morita, Takayuki Imai, Kenichiro Takahashi, Atsushi Yoshida, Shigeki Bamba, Osamu Inatomi, Akira Andoh. Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02271-4
|
9 |
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, M. V. Shashkov, A. S. Sokolova, I. N. Yakovina, A. V. Borisova. Fatty Acids of Erythrocyte Membranes and Blood Serum in Differential Diagnosis of Inflammatory Bowel Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 50 doi: 10.22416/1382-4376-2022-32-4-50-67
|
10 |
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 2021; 11(12): 1375 doi: 10.3390/life11121375
|
11 |
Kacper Nijakowski, Rafał Rutkowski, Piotr Eder, Katarzyna Korybalska, Janusz Witowski, Anna Surdacka. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease. Life 2021; 11(12): 1409 doi: 10.3390/life11121409
|
12 |
M. Pehrsson, M. S. Alexdóttir, M. A. Karsdal, P. Thakker, J.H. Mortensen. Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 575 doi: 10.1080/17474124.2023.2212158
|
13 |
Sophie Vieujean, Romain Gillard, Pierre Delanaye, Laurence Seidel, Emeline Bequet, Catherine Salée, Marie-Alice Meuwis, Charlotte Massot, Nicolas Pierre, Paul Meunier, Etienne Cavalier, Edouard Louis. Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology 2024; 59(3): 296 doi: 10.1080/00365521.2023.2286913
|
14 |
Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51580-z
|
15 |
Anke L Nguyen, Claudia Brick, David Liu, David J Gibson, Peter R Gibson, Miles P Sparrow. Clinical utility of C‐reactive protein‐to‐albumin ratio in the management of patients with inflammatory bowel disease. JGH Open 2024; 8(4) doi: 10.1002/jgh3.13059
|